Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 12;10(1):1718.
doi: 10.1038/s41467-019-08737-6.

Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis

Affiliations

Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis

Yongjie Yang et al. Nat Commun. .

Abstract

Hypothalamic neurons expressing the anorectic peptide Pro-opiomelanocortin (Pomc) regulate food intake and body weight. Here, we show that Steroid Receptor Coactivator-1 (SRC-1) interacts with a target of leptin receptor activation, phosphorylated STAT3, to potentiate Pomc transcription. Deletion of SRC-1 in Pomc neurons in mice attenuates their depolarization by leptin, decreases Pomc expression and increases food intake leading to high-fat diet-induced obesity. In humans, fifteen rare heterozygous variants in SRC-1 found in severely obese individuals impair leptin-mediated Pomc reporter activity in cells, whilst four variants found in non-obese controls do not. In a knock-in mouse model of a loss of function human variant (SRC-1L1376P), leptin-induced depolarization of Pomc neurons and Pomc expression are significantly reduced, and food intake and body weight are increased. In summary, we demonstrate that SRC-1 modulates the function of hypothalamic Pomc neurons, and suggest that targeting SRC-1 may represent a useful therapeutic strategy for weight loss.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
SRC-1 potentiates STAT3-induced Pomc expression. Numbers of mice/repeats in each group are indicated; data are presented as mean ± SEM and compared using T-tests or two-way ANOVA followed by post hoc Sidak tests (#). a Pomc and Socs3 mRNA levels in hypothalami from 16-week old SRC-1-KO and WT control littermates (n = 7/8); **P < 0.01. b ChIP assays detecting pSTAT3 binding on Pomc promoters in hypothalami from male SRC-1-KO and control littermates 30 min after leptin injections (5 mg/kg, i.p.): site 1, −998 to −989; site 2, −361 to −353; site 3, −76 to −68 upstream of Pomc (n = 3/4); *P < 0.05. c, d Effects of overexpressed constitutively active STAT3 and SRC-1 on Pomc- (c) or Socs3-luciferase activity (d) in Neuro2A cells (n = 5–9 independent experiments). ***P < 0.001 vs. empty vectors; ###P < 0.001 vs. STAT3 alone (#). e Change (∆) in body weight after male control and pomcSRC-1-KO mice were switched onto a HFD at day 97 (n = 6/9); *P < 0.05 and **P < 0.01 (#). f Fat mass and lean mass measured 28 days after HFD feeding (n = 6/9); *P < 0.05. g Energy intake measured by CLAMS chambers in 12-week old male mice matched for body weight, lean mass, and fat mass. Mice were subjected to a 2-day-chow–2-day-HFD protocol, and chow was replaced by HFD before the onset of dark cycle on day 3. Energy intake was averaged for 2-day chow feeding period and for 2-day HFD feeding period (n = 7/8); *P < 0.05. h Cumulative HFD intake measured in 12-week old male mice singly housed in home cages (n = 10/14); *P < 0.05 (#). i Change in body weight after control and MpomcSRC-1-KO mice were switched on a HFD at the age of day 84 (n = 8); *P < 0.05 (#). j Fat mass and lean mass measured 30 days after HFD feeding (n = 8); *P < 0.05. k Cumulative HFD intake measured in 12-week old male mice (n = 6/7); *P < 0.05 (#), **P < 0.01. Source data are provided as Source Data Fig. 1
Fig. 2
Fig. 2
SRC-1 mediates leptin signaling. Numbers of mice/experiments/neurons are indicated; data are presented as mean ± SEM and compared using T-tests or one- or two-way ANOVA followed by post hoc Sidak tests (#). a Serum leptin levels 42 days after HFD feeding (n = 5/8); *P < 0.05. b Time course of hypothalamic SRC-1-pSTAT3 interaction in C57Bl6 wild type mice that received i.p. injections of leptin (5 mg/kg). c Quantification of the hypothalamic SRC-1-pSTAT3 interaction. *P < 0.05 (#). d Two-hour fasted mice (12 weeks of age) received i.p. injections of saline or leptin (5 mg/kg) 15 min prior to refeeding and food intake was recorded for 1 h afterwards (n = 7/9); **P < 0.01 (#). e Representative pSTAT3 immunohistochemical staining in the ARH and VMH of control and pomcSRC-1-KO mice receiving a single bolus i.p. injection of leptin (0.5 mg/kg, 90 min). Scale bar = 50 μm. 3V the 3rd ventricle, ARH arcuate nucleus, VMH ventromedial hypothalamic nucleus. f Quantification of pSTAT3 (+) neurons in the ARH (n = 5); ***P < 0.001. g Representative traces of leptin-induced depolarization, in the presence of TTX, CNQX, DAP-5, and bicuculline, in mature Pomc neurons from control mice vs. from MpomcSRC-1-KO mice after 1-week HFD feeding. h Responsive ratio (depolarization is defined as >2 mV elevations in resting membrane potential) (n = 39/43); P = 0.002 in χ2 tests. i Quantification of leptin-induced depolarization in two groups (n = 39/43); **P < 0.01. j Representative traces of action potentials in untreated mature Pomc neurons from control mice vs. from MpomcSRC-1-KO mice. k, l Quantification of firing frequency (k) and resting membrane potential (l) in two groups (n = 29–36); *P < 0.05. m Representative traces of mIPSC in untreated mature Pomc neurons from control mice vs. from MpomcSRC-1-KO mice. n, o Quantification of amplitude (n) and frequency (o) of mIPSC in two groups (n = 13/14); ***P < 0.001. Source data are provided as Source Data Fig. 2
Fig. 3
Fig. 3
Missense variants in SRC-1 disrupt leptin signaling. Numbers of experiments are indicated; data are presented as mean ± SEM and compared using one-way ANOVA followed by post hoc Sidak tests unless mentioned otherwise. a Rare variants identified in individuals with severe early onset obesity (above) and in controls (below). b, c HEK293 cells were co-transfected with leptin receptor vector and human STAT3 vector. Cells were treated with leptin (200 ng/ml, 15 min) to induce phosphorylation of STAT3. pSTAT3 was pulled down using anti-pSTAT3 sepharose beads; beads were then aliquoted equally and incubated with the same amount of the long isoform of human SRC-1-HA (WT/mutant) and interactions between the pSTAT3 and SRC-1 were determined by CoIP experiments using anti-pSTAT3 and anti-HA antibodies. b Representative blots showing interactions between pSTAT3 and SRC-1 (WT/mutant), and inputs of pSTAT3 and SRC-1-HA. c Quantification for WT and SRC-1 mutants. Comparative folds were calculated as the ratios of HA blots and HA inputs (n = 3–5); *P < 0.05. d, e SRC-1 mutants inhibit the interaction between STAT3 and WT SRC-1. HEK293 cells were co-transfected with leptin receptor vector, STAT3 vector, and mutant SRC-1 vector (or empty vector). Cells were treated with leptin (200 ng/ml, 15 min) to induce phosphorylation of STAT3 and interactions between pSTAT3 and total SRC-1 were determined by CoIP experiments using anti-pSTAT3 and anti-SRC-1 antibodies. d Representative blots showing interactions between pSTAT3 and SRC-1 variants found in obese cases and inputs of pSTAT3. e Quantification. Comparative folds were calculated as the ratios of SRC-1-pSTAT3 interaction blots and pSTAT3 inputs (n = 4–12); *P < 0.05. f SRC-1 variants impair POMC expression. Neuro2A cells were co-transfected with leptin receptor vector, SRC-1 (WT or mutant) and a POMC luciferase expression reporter construct. Cells were stimulated with 200 ng/ml leptin for 15 min and then incubated for 6 h, following which luminescence was measured. Results were normalized to empty vector-induced expression (n = 3–16); *P < 0.05. Source data are provided as Source Data Fig. 3
Fig. 4
Fig. 4
SRC-1L1376P/+ mice are obese. Numbers of mice in each group are indicated; data are presented as mean ± SEM and compared using T-tests or two-way ANOVA followed by post hoc Sidak tests (#). a The PCR products (121 bp) around the L1376 were amplified from genomic DNA extracts of a WT and two SRC-1L1376P/+ mutant mice and incubated with or without Sau3AI. Control reaction (WT) resulted in a single large fragment (121 bp) and DNAs from the two SRC-1L1376P/+ mutant mice were cut into two fragments (70 and 51 bp) as expected. b Change in body weight after male control and SRC-1L1376P/+ mice were fed on a HFD (n = 5/6); *P < 0.05 (#). c Fat mass and lean mass measured 7 weeks after HFD feeding (n = 5/6); ***P < 0.001. d Cumulative HFD intake measured (n = 5/6); *P < 0.05 or **P < 0.01 (#). e Pomc mRNA levels in hypothalami from 20-week old HFD-fed male control and SRC-1L1376P/+ mice (n = 12/16); *P < 0.05. f Representative traces of leptin-induced depolarization, in the presence of TTX, CNQX, DAP-5, and bicuculline, in Pomc neurons from control mice vs. from SRC-1L1376P/+ mice after 1-week HFD feeding. g Responsive ratio (depolarization is defined as >2 mV elevations in resting membrane potential) (n = 19); P = 0.022 in χ2 tests. h Quantification of leptin-induced depolarization in two groups (n = 19); ***P < 0.001. i Representative traces of action potentials in untreated Pomc neurons from control mice vs. from SRC-1L1376P/+ mice. j, k Quantification of firing frequency (j) and resting membrane potential (k) in two groups (n = 22–28); ***P < 0.001. l Representative traces of mIPSC in untreated Pomc neurons from control mice vs. from SRC-1L1376P/+ mice. m, n Quantification of amplitude (m) and frequency (n) of mIPSC in two groups (n = 10/12); ***P < 0.001. Source data are provided as Source Data Fig. 4

References

    1. Dasgupta S, Lonard DM, O’Malley BW. Nuclear receptor coactivators: master regulators of human health and disease. Annu. Rev. Med. 2014;65:279–292. doi: 10.1146/annurev-med-051812-145316. - DOI - PMC - PubMed
    1. York B, O’Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J. Biol. Chem. 2010;285:38743–38750. doi: 10.1074/jbc.R110.193367. - DOI - PMC - PubMed
    1. Picard F, et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell. 2002;111:931–941. doi: 10.1016/S0092-8674(02)01169-8. - DOI - PubMed
    1. Zhu L, et al. Steroid receptor coactivator-1 mediates estrogenic actions to prevent body weight gain in female mice. Endocrinology. 2013;154:150–158. doi: 10.1210/en.2012-2007. - DOI - PMC - PubMed
    1. Hill JW, Elmquist JK, Elias CF. Hypothalamic pathways linking energy balance and reproduction. Am. J. Physiol. Endocrinol. Metab. 2008;294:E827–E832. doi: 10.1152/ajpendo.00670.2007. - DOI - PMC - PubMed

Publication types

MeSH terms